CN111437301A - Sophora flower cordyceps militaris preparation - Google Patents
Sophora flower cordyceps militaris preparation Download PDFInfo
- Publication number
- CN111437301A CN111437301A CN202010404779.9A CN202010404779A CN111437301A CN 111437301 A CN111437301 A CN 111437301A CN 202010404779 A CN202010404779 A CN 202010404779A CN 111437301 A CN111437301 A CN 111437301A
- Authority
- CN
- China
- Prior art keywords
- cordyceps militaris
- sophora flower
- preparation
- blood
- cough
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 241000219784 Sophora Species 0.000 title claims abstract description 15
- 240000008672 Gynura procumbens Species 0.000 claims abstract description 10
- 235000018457 Gynura procumbens Nutrition 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 7
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 abstract description 26
- 206010011224 Cough Diseases 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 11
- 206010035664 Pneumonia Diseases 0.000 abstract description 8
- 208000006673 asthma Diseases 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 8
- 201000006306 Cor pulmonale Diseases 0.000 abstract description 7
- 206010016654 Fibrosis Diseases 0.000 abstract description 7
- 241000282414 Homo sapiens Species 0.000 abstract description 7
- 208000004186 Pulmonary Heart Disease Diseases 0.000 abstract description 7
- 208000019425 cirrhosis of liver Diseases 0.000 abstract description 7
- 208000002672 hepatitis B Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 206010003445 Ascites Diseases 0.000 abstract description 6
- 241000700605 Viruses Species 0.000 abstract description 6
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 6
- 230000007882 cirrhosis Effects 0.000 abstract description 6
- 230000002440 hepatic effect Effects 0.000 abstract description 6
- 230000002458 infectious effect Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 208000005801 spondylosis Diseases 0.000 abstract description 6
- 230000000740 bleeding effect Effects 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 241000222336 Ganoderma Species 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000000552 rheumatic effect Effects 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000001579 Cirsium arvense Species 0.000 abstract 1
- 235000005918 Cirsium arvense Nutrition 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 241000229143 Hippophae Species 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 241000628997 Flos Species 0.000 description 5
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 description 5
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000931705 Cicada Species 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241001237431 Anomala Species 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 235000014290 Artemisia anomala Nutrition 0.000 description 1
- 241000123844 Artemisia anomala Species 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047097 Vascular purpura Diseases 0.000 description 1
- 206010053649 Vascular rupture Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000006493 arterial relaxation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- GWTUHAXUUFROTF-UHFFFAOYSA-N pseudochlorogenic acid Natural products C1C(O)C(O)C(O)CC1(C(O)=O)OC(=O)C=CC1=CC=C(O)C(O)=C1 GWTUHAXUUFROTF-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The sophora flower cordyceps militaris preparation is prepared from: 400-800 g of sophora flower, 300-600 g of cordyceps militaris, 300-600 g of gynura procumbens, 300-600 g of sea-buckthorn, 200-400 g of emblic leafflower fruit and 100-200 g of field thistle have the functions of clearing heat and detoxicating, protecting liver, promoting blood circulation and dissolving in the blood, cooling blood and stopping bleeding, inducing diuresis and improving human immunity, can effectively treat hepatitis B, cirrhosis, hepatic ascites, rheumatic osteodynia, cervical spondylosis, lumbar spondylosis, cough, asthma and pulmonary heart disease, is a pure medicinal food homologous agent and has no toxic effect, and can be added with Guangdong diverse wormwood herb, lucid ganoderma and angelica dahurica as auxiliary materials to enhance the curative effect of treating the severe virus infectious pneumonia and the complications thereof.
Description
The technical field is as follows: the invention belongs to the field of medicine and food homology, and particularly relates to a sophora flower cordyceps militaris preparation.
Background art: with the rapid development of society, the working pressure of people also increases, the understanding of part of people on health preservation and body building is not enough, the immunity is more and more low with the increase of age, people who are taken from sub-healthy people for a long time do not pay attention to the self body conditioning, and the disease is accumulated for a long time and cannot be cured for the last time, and is forwarded to become a serious difficult disease; such as: hepatitis B, cirrhosis, hepatic ascites, rheumatism ostalgia, asthma, pulmonary heart disease, these diseases have become the rising trend at present, the Chinese and western medicine for treating these diseases is various, but most of them are not good in effect, need to be taken for a long time, and have great side effects, cause many complications, for this reason people wait for a medicine that can effectively treat above many diseases, and have no toxic and side effects to come out urgently, in the course of going a doctor, build the research institute of traditional Chinese medicine, collect various folk prescriptions and secret recipe and recombine, used in clinic, have made a major breakthrough to above diseases, the prescription is used by: flos sophorae, cordyceps militaris, gynura procumbens, sea buckthorn, emblic leafflower fruit and herba cepbalanoplosis segeti, thousands of cases of patients suffering from hepatitis B, cirrhosis, hepatic ascites, cervical spondylosis, lumbar spondylopathy, rheumatoid diseases and viral infectious pneumonia are cured by using the traditional Chinese medicine preparation, the effective rate is more than 90%, the preparation is found in the further research and development process, a small amount of herba artemisiae anomala, lucid ganoderma and angelica dahurica are added into the traditional Chinese medicine preparation based on the proportion, the curative effects of the preparation on the pharyngitis, the cough, the asthma and the pulmonary heart disease caused by the heavy viral infectious pneumonia can be improved, no preparation with good curative effects exists in the human face of the novel coronary infectious pneumonia, the researched flos sophorae cordyceps militaris preparation, the skilled wood is mature, the raw materials such as cordyceps militaris, gynura procumbens and the like in the formula can be further extracted and purified, and a mouse test model for treating the new coronavirus infectious pneumonia is established by injecting the new coronavirus, then different dosages are given for curative effect evaluation and safe dose evaluation, and then the medicine is used for effectively preventing and treating pneumonia people infected by the new coronavirus, and great contribution is made to human beings.
The invention content is as follows: the sophora flower cordyceps militaris preparation is prepared from: 400g-800g of sophora flower, 300g-600g of cordyceps militaris, 300g-600g of gynura procumbens, 300g-600g of sea buckthorn, 200g-400g of emblic leafflower fruit and 100g-200g of common cephalanoplos herb, has the functions of clearing heat and removing toxicity, protecting liver, promoting blood circulation and dissolving in the body, cooling blood and stopping bleeding, inducing diuresis and improving human immunity, and can effectively treat hepatitis B, cirrhosis, hepatic ascites, rheumatoid diseases, cervical spondylosis, lumbar spondylosis and pharyngitis, cough, asthma, pulmonary heart disease and cardiovascular and cerebrovascular diseases complicated with viral pneumonia, and has the effects of pure medicinal food homologous preparation and no toxicity; the preparation prepared from 400g of sophora flower, 300g of cordyceps militaris, 300g of gynura procumbens, 300g of sea buckthorn, 200g of emblic leafflower fruit and 100g of herba cephalanoploris is adopted by ancestral grandparents to treat the diseases, the curative effect is obvious, the ancestral secret recipe is handed to the inventor, the inventor conducts prescription recombination on the prescription for hundreds of times, the curative effect of the combined preparation is weaker than that of the original prescription, and the optimal prescription of the prescription in the ratio of the grandparents is determined; each traditional Chinese medicine in the formula is homologous in medicine and food, and has different functions, wherein the efficacy and the function of the sophora flower are as follows: 1. the sophora flower contains a large amount of rutin, which is an important substance for increasing the resistance of capillary vessels, can improve the functions of the capillary vessels, increase the elasticity of vessel walls and greatly reduce the probability of cerebral vascular rupture of people, thereby playing a role in preventing stroke and hypertension; 2. clearing liver-fire, because flos Sophorae Immaturus enters liver meridian, it also has good therapeutic effects on vigorous liver fire, headache and conjunctival congestion, sore throat, aphonia, carbuncle, ulcer and sore and ulcer; 3. the sophora flower is bitter in taste and slightly cold in nature, belongs to liver and large intestine channels in the theory of traditional Chinese medicine, is a substance with high medicinal value, has the special efficacy of cooling blood and stopping bleeding, is mainly used for matching and treating bleeding and blood-heat type diseases clinically, and has good curative effects on hematochezia, hematuria, hemorrhoidal bleeding and other diseases; 4. anti-inflammatory and antibacterial effects, wherein rutin, sophoricediol and various saccharides contained in flos Sophorae Immaturus can rapidly kill harmful substances in human blood, prevent their circulation in human body, and prevent various inflammations, and the juice of flos Sophorae Immaturus applied on skin can resist fungi; sea-buckthorn: has the effects of strengthening spleen and promoting digestion, relieving cough and reducing sputum, and activating blood and dissolving stasis, is mainly used for clinically treating clinical manifestation symptoms such as weakness of spleen and stomach function, cough, expectoration and the like in the body, in addition, the sea buckthorn is frequently eaten, has good effects of protecting liver, promoting metabolism of liver function, reducing damage caused by liver function, improving liver function, resisting liver cirrhosis and resisting fatty liver, fructus Hippophae contains abundant vitamins and multiple celluloses, the sea-buckthorn has obvious anticancer activity and anticancer effect on cancerous tissues, certain inhibiting and killing effect on cancer cells in vivo, good conditioning and treating effect on low immunity, skin beautifying and neurasthenia, obvious effects of resisting myocardial ischemia and improving arterial spasm, and effects of resisting myocardial ischemia injury and reducing myocardial infarction area on experimental animals. Can obviously inhibit ventricular fibrosis, and the seabuckthorn flavone produces arterial relaxation effect by stimulating the generation of prostacyclin and endothelial relaxation factor, maintains the tension of arterial and venous vessels together, increases the blood flow of injured parts and surrounding tissues, improves the permeability of vessel walls, and has the fundamental effects of: cleaning blood, removing blood toxin, purifying blood, dredging blood vessel, improving intestine and stomach, consolidating sleep, and prolonging life; cordyceps militaris: also named as Cordyceps militaris, Cordyceps militaris bacteria, etc., according to the research of Chinese medicine experts, the cordycepin contained in Cordyceps militaris is high, and the anti-aging and anti-superoxide dismutase (SOD) content is 2 times higher than that of aloe. Zhao Zhimin in Ben Cao gang mu Shi Yi (supplement to compendium of materia Medica) classifies the herbs of Chong Cao as "treating deficiency and damage". Li Shizhen is indicated in Ben Cao gang mu that Chan Hua can be indicated for infantile convulsions, night cry and palpitation. Wherein the cicada fungus comprises a plurality of cordyceps sinensis parasitizing on cicada bodies, such as cicada grass, cordyceps militaris and the like. Research for many years shows that the cordyceps militaris contains various effective components such as cordycepin, cordycepic acid, polysaccharide, adenosine and the like, can reduce blood fat, prevent arteriosclerosis, protect heart and brain tissues, calm and hypnotize, enhance the activity of macrophages, resist inflammation, cancer, bacteria and aging and the like; emblic leafflower fruit: has cool nature, and can be used for clearing heat, cooling blood, moistening lung, relieving discomfort such as heatstroke, wind-heat, chronic pharyngitis, etc., and treating diabetes, hypertension, hyperlipidemia, diabetes, dyspepsia, etc.; gynura procumbens (lour.) Merr: the edible tender stem leaves have the effects of clearing away heat and toxic materials, stopping bleeding, relieving cough, reducing vascular purpura, improving immunity and resisting virus; purging pathogenic fire, cooling blood, relieving inflammation, promoting fluid production, etc., and has certain therapeutic effect on swelling disease; through the safety evaluation and research, gynura procumbens is a non-toxic high-quality special health-care vegetable, and the rhizome is a superior raw material of Chinese patent medicine. The edible or medicinal dish can supplement calcium, resist virus, cold and improve immunity, has good curative effect on herpes zoster, dermatitis, scald, burn and innominate swelling and pain, and also has hemostatic, analgesic, antipruritic, skin caring, moisturizing and antiaging effects; according to the records in the book of Chinese herbal medicine assembly: the medicine has the curative effects of sweet and light taste, mild nature, clearing and activating the channels and collaterals, diminishing inflammation and relieving cough, eliminating stasis and swelling, and promoting blood circulation and promoting tissue regeneration, and is mainly used for treating traumatic injury, rheumatic arthralgia and gout; through nutrition and chemical analysis, the plant is rich in organic calcium and is the best calcium-supplementing green food for the middle-aged and the elderly; the gynura procumbens contains rich organic acid components and flavonoid compounds, and the neochlorogenic acid in the organic acid components has good effects of resisting viruses and enhancing the immunity of a human body, has a remarkable effect of inhibiting hepatitis B viruses and also has the effect of resisting AIDS viruses and influenza viruses; herba Cirsii: can be used for treating hematemesis, maggot blood, hematuria, hematochezia, metrorrhagia, traumatic hemorrhage, carbuncle, suppurative sore, eczema, jaundice, hepatitis, nephritis, hypertension, bronchiectasis hemoptysis, digestive tract hemorrhage, hemorrhoid hemorrhage, functional uterine hemorrhage, puerperal uterine insufficiency, bacillary dysentery, skin ulcer, and traumatic pyogenic infection; the pure traditional Chinese medicines are used as foods for thousands of years, the pure traditional Chinese medicines are homologous in food, have no toxic or side effect, can be added or reduced in dosage according to requirements, and can be added with the auxiliary materials of the artemisia anomala (Sijicai), the lucid ganoderma and the angelica dahurica for treating the complication of the severe virus infectious pneumonia, so that the immune function of a patient is improved, the aim of quick recovery is fulfilled, the preparation can be developed into tea drinks (solid drinks), health-care foods and Chinese patent medicines, and meanwhile, the medicine can also be prepared into medicine-food homologous health-care wine by taking certain high-quality wine as base wine and adding sophora flower cordyceps militaris preparation.
The preparation method comprises the following steps: the preparation method comprises the steps of selecting 4Kg of sophora flower, 3Kg of cordyceps militaris, 3Kg of gynura procumbens, 3Kg of sea-buckthorn, 2Kg of emblic leafflower fruit and 1Kg of common cephalanoplos herb, concentrating for multiple times, adding a proper amount of auxiliary materials to prepare 16Kg of concentrated powder, and bottling for later use.
The dosage and the usage are as follows: the medicine is taken with warm boiled water 2 times a day, 3.3 g each time.
Example (b): <1>, Tan XX, women and 48 years old, due to the fact that the cervical spondylosis and the lumbar spondylosis and the rheumatoid disease are not cured for a long time, the pain of the whole body and joints is difficult to endure, no obvious improvement is achieved for one year after treatment in a hospital, treatment is carried out in 8, 9 days in 2008, the people open the pagodatree flower cordyceps militaris preparation prepared by the preparation method to stop taking other Chinese and western medicines, the pagodatree flower cordyceps militaris preparation is taken twice a day and 3.3 g each time, after being taken for 15 days, the pagodatree flower cordyceps militaris preparation is obviously improved, after being taken for 4 months, the pagodatree flower cordyceps militaris preparation is taken again in the hospital, the cervical spondylosis, the lumbar spondylosis and the rheumatoid disease are all recovered, the body is all normal, and the cervical spondylosis and the lumbar spondylosis are not recovered along with imitating three years.
<2>, ginger ×, male and 55 years old, pneumonia can not be cured due to virus infection, asthma and pulmonary heart disease are converted, various western medicines are used in hospitals for 2 years, symptoms are not obviously improved, physical abnormality can be sensed when medicine is stopped, life quality is not ideal, the male and female patients are in a disease-critical state at any time, the whole-generation breathing machine can maintain life and live as long as possible, the pagodatree flower cordyceps militaris preparation prepared by the preparation method is taken in 8 days 4 and 8 days 2011, other medicines are stopped taking, 6.6g of the preparation is taken twice a day each time, the state of illness is controlled after one month, general labor can be normally engaged, the dosage is reduced by half after the second month, five months are taken continuously, all normal conditions are achieved, and no relapse occurs after medicine is stopped, and the health is achieved at present.
<3>, ××, male, 60 years old, found three positive and three positive hepatitis B in 11 months and 1 days in 2002, mild abnormal liver function, not cured in hospitals of large and small, 1 month and 1 day in 2009, because of cough caused by cold, cough aggravated by cough after several days, accompanied by asthma and weakness, tachycardia, go to large hospital for examination, diagnosis of cirrhosis and hepatic ascites caused by hepatitis B, accompanied by cough, asthma and pulmonary heart disease, no obvious improvement of various Chinese and western medicines after taking, feeling of whole body discomfort all day, no improvement of several months in hospital for treatment, 6.6g of cordyceps militaris each time and 3 times a day (stopping taking the medicines), after 20 days of use, obvious improvement of feeling, continuous use of 9 months to hospital for reexamination, cirrhosis and hepatic ascites are recovered, three positive and three negative hepatitis B are changed, hepatitis B virus is changed into negative, asthma and pulmonary heart disease are controlled, no stopping feeling of any medicine, reaching the clinical standard, no clinical work is found, and no cough and normal cough appear.
Claims (1)
1. The sophora flower cordyceps militaris preparation is characterized by comprising the following components: 400g of sophora flower, 300g of cordyceps militaris, 300g of gynura procumbens, 300g of sea buckthorn, 200g of emblic leafflower fruit and 100g of common cephalanoplos herb.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404779.9A CN111437301A (en) | 2020-05-03 | 2020-05-03 | Sophora flower cordyceps militaris preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404779.9A CN111437301A (en) | 2020-05-03 | 2020-05-03 | Sophora flower cordyceps militaris preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111437301A true CN111437301A (en) | 2020-07-24 |
Family
ID=71657534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010404779.9A Pending CN111437301A (en) | 2020-05-03 | 2020-05-03 | Sophora flower cordyceps militaris preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111437301A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113244275A (en) * | 2021-07-02 | 2021-08-13 | 上海市公共卫生临床中心 | Application of cordyceps militaris medicinal composition in preparation of preparation for preventing and/or treating neocorona and resisting respiratory viruses |
-
2020
- 2020-05-03 CN CN202010404779.9A patent/CN111437301A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113244275A (en) * | 2021-07-02 | 2021-08-13 | 上海市公共卫生临床中心 | Application of cordyceps militaris medicinal composition in preparation of preparation for preventing and/or treating neocorona and resisting respiratory viruses |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105995720A (en) | Enzyme Laiyang pear paste and preparation method and application thereof | |
CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
CN113041293A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
CN103720903A (en) | Anti-inflammation lung-clearing and liver-protecting tea and preparation method thereof | |
CN102600417B (en) | Traditional Chinese medicine composition for treating rumen bloat in cattle and sheep | |
CN102552779A (en) | Health-care traditional Chinese medicine composition with effect of human body blood purification and health-care product thereof | |
CN111437301A (en) | Sophora flower cordyceps militaris preparation | |
CN106038743A (en) | Blood pressure reducing electuary, and preparation method and application thereof | |
CN103007145B (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN102579872B (en) | Medical composition with weight reducing function | |
CN102698185B (en) | Traditional Tibetan medicine for treating hyperlipidemia and preparation method thereof | |
CN101669995A (en) | Composite for treatment and health care of heart cerebrovascular diseases and preparation method thereof | |
CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
CN104524461A (en) | Medicine composition for treating myocarditis and application thereof | |
CN115252732B (en) | Traditional Chinese medicine composition for clearing lung and relieving cough and application thereof | |
CN108713711A (en) | Chinese medicine health-care composition, solid health-care beverage and its preparation method and application | |
CN107213283A (en) | A kind of antifatigue, Yin Yang balancing food and medicament dual-purpose Chinese medicine composition and preparation method thereof | |
CN101837062B (en) | Lipid-lowering buccal tablets | |
CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
CN105125886A (en) | Traditional Chinese medicine composition for preventing and treating diabetes and complications of diabetes | |
CN113144079A (en) | Traditional Chinese medicine preparation for preventing and treating influenza and preparation method thereof | |
CN104998189A (en) | Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof | |
CN104825883A (en) | Traditional Chinese medicine prescription for treating rhinitis | |
CN104758757A (en) | Traditional Chinese medicine composition for treating tinea pedis and preparation method thereof | |
CN108704109A (en) | A kind of Chinese medicine composition and preparation method thereof for treating acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200724 |
|
WD01 | Invention patent application deemed withdrawn after publication |